Research Matters Blog


Updates from MUSC's Offices of Research Administration

SCTR & FRD Technology Development Grants


SCTR & FRD Technology Development Grants


Key Dates:
Pre-Application Opens: January 2, 2017
Pre-Application Due: January 17, 2017
Invitation to Submit Full Application: January 31, 2017
Full Application Due: February 23, 2017

SCTR’s Therapeutics Translation Core (TTC), in conjunction with the MUSC Foundation for Research Development (FRD) and the MUSC Drug Discovery Core, aims to accelerate academic innovations into marketed products by providing gap funding of up to $25,000 to advance innovative, clinically relevant technologies. The awards support short-term (six month) studies designed to improve the commercial value of the technologies by strengthening the intellectual property (IP) and moving technologies further down the development pathway, thus increasing the partnerships and licensing opportunities with pharmaceutical and biotechnology companies.

The primary objective of the gap funding awards is to support projects that have a high chance of being commercialized, but that are not likely to get there without gap funding. Funds are intended to advance projects to the next developmental milestone by enabling investigators to conduct additional experiments, such as those that

  • Optimize compounds, conduct toxicology studies, or help define a pharmacological target or translational biomarker
  • Prototype a device
  • Build or validate a software program

Please note:

This RFA is open to advance technologies protected by, or protectable by, IP that is assigned or assignable to MUSC pursuant the MUSC IP Policy. If a patent or patent application is not currently assigned to FRD, a Record of Invention must be on file with FRD at least one month in advance of the Pre-Application open date.

For more information, contact Ford Simmons at